Tandem Diabetes Care Stock Forecast

Stock Price Forecast

The 19 analysts that cover Tandem Diabetes Care stock have a consensus rating of "Buy" and an average price target of $26.95, which forecasts a 2.55% increase in the stock price over the next year. The lowest target is $12 and the highest is $55.

Price Target: $26.95 (+2.55%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$26.95	$24	$55
Change	-54.34%	+2.55%	-8.68%	+109.28%

Analyst Ratings

The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	2	2	2	2	2	3
Buy	4	4	3	4	4	4
Hold	10	11	11	10	11	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	17	16	16	17	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Hold → Strong Buy Upgrades $50	Hold → Strong Buy	Upgrades	$50	+90.26%	Feb 23, 2026
Richard Newitter Truist Securities	Truist Securities	Hold Reiterates $24 → $27	Hold	Reiterates	$24 → $27	+2.74%	Feb 23, 2026
Anthony Petrone Mizuho	Mizuho	Hold Maintains $21 → $22	Hold	Maintains	$21 → $22	-16.29%	Feb 20, 2026
Danielle Antalffy UBS	UBS	Hold Maintains $17 → $22	Hold	Maintains	$17 → $22	-16.29%	Feb 20, 2026
Jonathan Block Stifel	Stifel	Hold Maintains $20 → $22	Hold	Maintains	$20 → $22	-16.29%	Feb 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.13B

from 1.01B

10.96%

from 1.01B

Revenue Next Year

1.23B

from 1.13B

9.33%

from 1.13B

EPS This Year

-0.98

from -3.04

EPS Next Year

-0.24

from -0.98

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	702.80M	801.22M	747.72M	940.20M	1.01B	1.13B	1.23B
Revenue Growth	40.89%	14.00%	-6.68%	25.74%	7.93%	10.96%	9.33%
EPS	0.24	-1.47	-3.43	-1.47	-3.04	-0.98	-0.24
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	27	24

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.2B	1.3B
Avg	1.1B	1.2B
Low	1.0B	1.1B

Revenue Growth

Revenue Growth	2026	2027
High	17.7%	16.0%
Avg	11.0%	9.3%
Low	3.1%	0.2%

EPS Forecast

EPS	2026	2027
High	-0.61	0.36
Avg	-0.98	-0.24
Low	-2.34	-1.75

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.